EG ·
COZAAR 50mg 14/TAB
COZAAR 50mg 14/TAB
Composition
These source-reported data require scientific review and are not treatment advice.
LOSARTAN POTASSIUM
· AMOUNT_PER_UNIT
LOSARTAN POTASSIUM
· AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| COZAAR 100mg 7 /TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| KANZAR 50mg 7/TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| KANZAR 25mg 7/TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| COZAAR 50 mg 7 /TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| COZAAR 100 MG 14 TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| KANZAR 100 MG 4 TAB | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| MODAZAR 8TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| AMOSAR 25mg 20/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| REMTOZAR 100MG 10/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| LOSARMEPHA 5012.5MG 7TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| LOSARTAN 14TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| KANZAR- E 100 MG 4 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |